Enlitic Inc (ENL) - Net Assets
Based on the latest financial reports, Enlitic Inc (ENL) has net assets worth AU$10.36 Million AUD (≈ $7.33 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$14.60 Million ≈ $10.33 Million USD) and total liabilities (AU$4.24 Million ≈ $3.00 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read Enlitic Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$10.36 Million |
| % of Total Assets | 70.95% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Enlitic Inc - Net Assets Trend (2022–2024)
This chart illustrates how Enlitic Inc's net assets have evolved over time, based on quarterly financial data. Also explore ENL total asset value for the complete picture of this company's asset base.
Annual Net Assets for Enlitic Inc (2022–2024)
The table below shows the annual net assets of Enlitic Inc from 2022 to 2024. For live valuation and market cap data, see ENL stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | AU$11.03 Million ≈ $7.80 Million |
+0.80% |
| 2023-12-31 | AU$10.94 Million ≈ $7.74 Million |
+139.55% |
| 2022-12-31 | AU$-27.66 Million ≈ $-19.57 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Enlitic Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3372978500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$128.17 Million | 1162.21% |
| Other Comprehensive Income | AU$3.23 Million | 29.25% |
| Total Equity | AU$11.03 Million | 100.00% |
Enlitic Inc Competitors by Market Cap
The table below lists competitors of Enlitic Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Macarthur Minerals Ltd
AU:MIO
|
$5.90 Million |
|
Eko Export SA
WAR:EEX
|
$5.90 Million |
|
Imagion Biosystems Ltd
AU:IBX
|
$5.90 Million |
|
CU Medical Systems Inc
KQ:115480
|
$5.90 Million |
|
KWANGJIN WINTEC CO. Ltd
KQ:090150
|
$5.89 Million |
|
HB Global Ltd
KLSE:5187
|
$5.89 Million |
|
Hilton Food Group Plc
LSE:HFG
|
$5.89 Million |
|
Ocean Glass Public Company Limited
BK:OGC
|
$5.88 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Enlitic Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 10,940,363 to 11,028,200, a change of 87,837 (0.8%).
- Net loss of 15,237,895 reduced equity.
- Share repurchases of 1,137,079 reduced equity.
- New share issuances of 15,607,404 increased equity.
- Other comprehensive income decreased equity by 94,593.
- Other factors increased equity by 950,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-15.24 Million | -138.17% |
| Share Repurchases | AU$1.14 Million | -10.31% |
| Share Issuances | AU$15.61 Million | +141.52% |
| Other Comprehensive Income | AU$-94.59K | -0.86% |
| Other Changes | AU$950.00K | +8.61% |
| Total Change | AU$- | 0.80% |
Book Value vs Market Value Analysis
This analysis compares Enlitic Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.17x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.00x to 0.17x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2023-12-31 | AU$2.29 | AU$0.01 | x |
| 2024-12-31 | AU$0.06 | AU$0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Enlitic Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -138.17%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1412.41%
- • Asset Turnover: 0.08x
- • Equity Multiplier: 1.29x
- Recent ROE (-138.17%) is below the historical average (-93.44%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 0.00% | -2770.80% | 0.29x | 0.00x | AU$-22.27 Million |
| 2023 | -142.15% | -3135.89% | 0.04x | 1.06x | AU$-16.65 Million |
| 2024 | -138.17% | -1412.41% | 0.08x | 1.29x | AU$-16.34 Million |
Industry Comparison
This section compares Enlitic Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $12,576,583
- Average return on equity (ROE) among peers: -100.02%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Enlitic Inc (ENL) | AU$10.36 Million | 0.00% | 0.41x | $5.90 Million |
| Adheris Health Limited (AHE) | $2.78 Million | -35.73% | 0.18x | $136.67 |
| Alcidion Group Ltd (ALC) | $4.03 Million | -3.69% | 0.00x | $95.02 Million |
| ARTRYA Ltd (AYA) | $16.80 Million | -83.31% | 0.13x | $455.29 Million |
| Beamtree Holdings Ltd (BMT) | $47.14 Million | -10.83% | 0.27x | $24.68 Million |
| Cogstate Ltd (CGS) | $1.84 Million | -38.77% | 0.44x | $291.33 Million |
| Careteq Ltd (CTQ) | $1.52 Million | -4.75% | 2.91x | $2.06 Million |
| Doctor Care Anywhere Group Plc (DOC) | $15.82 Million | -127.77% | 0.24x | $41.51 Million |
| Echoiq Ltd (EIQ) | $22.76 Million | -58.28% | 0.03x | $468.78 Million |
| Emyria Ltd (EMD) | $499.54K | -537.08% | 6.06x | $28.53 Million |
About Enlitic Inc
Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, and ultrasound images, as well as licenses its products to healthcare providers and original equipment manufacturers. Its hea… Read more